๐ต๏ธ Albany International Corp /DE/ ($AIN)
SEC insider & ownership activity, last 12 months ยท CIK 819793 ยท every row links its SEC filing
Over the last 12 months insiders bought $201K with no open-market selling against it. Kleveland Gunnar bought $201K in discretionary trades (AugโNov). No red-flag 8-Ks in the window.
๐จ 1 signal active โ
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $201K (2 lots) ยท 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Kleveland Gunnar | 2 | $201K | 0 | โ | Nov 17, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Blackrock, Inc. | 14.4% | 13G | Jul 18, 2025 | filing โ | |
| Vanguard Portfolio Management | 6.3% | 13G | Apr 28, 2026 | filing โ | |
| Vanguard Capital Management | 5.3% | 13G | Apr 29, 2026 | filing โ | |
| American Century Investment Management, Inc. | 5.1% | 13G | May 1, 2026 | filing โ | |
| American Century Companies, Inc. | 5.1% | 13G | May 1, 2026 | filing โ | |
| Stowers Institute for Medical Research | 5.1% | 13G | May 1, 2026 | filing โ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Robert D. Starr | $361K | Aug 5, 2025 | filing โ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Shareholder vote (5.07) | May 19, 2026 | filing โ |
| Earnings (2.02) | Apr 30, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Apr 30, 2026 | filing โ |
| Earnings (2.02) | Feb 24, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Feb 24, 2026 | filing โ |
| Reg FD disclosure (7.01) | Nov 25, 2025 | filing โ |
| Financial Statements and Exhibits (9.01) | Nov 5, 2025 | filing โ |
| Earnings (2.02) | Oct 28, 2025 | filing โ |
| Reg FD disclosure (7.01) | Oct 28, 2025 | filing โ |
| Financial Statements and Exhibits (9.01) | Oct 28, 2025 | filing โ |
| Earnings (2.02) | Jul 30, 2025 | filing โ |
| Financial Statements and Exhibits (9.01) | Jul 30, 2025 | filing โ |
| Officer/director changes (5.02) | Jul 30, 2025 | filing โ |
| Financial Statements and Exhibits (9.01) | Jul 30, 2025 | filing โ |